4-Hydroxy-4-(4-methoxyphenyl)butanoic acid, 98%, 25g

MOXIFLOXACIN, 95%, 1g

2,5-Dichloropyridine-3,4-diamine, 95.0%, 250mg

2,3-Dihydrofuro[3,2-c]pyridin-4-amine, 98%, 5g

ETHYL 1-CYCLOPROPYL-6,7-DIFLUORO-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLATE, 97.0%, 5g

4-Hydroxy-3-methoxy-benzaldehyde, 95.0%, 250g

1-Phenylpiperidine-4-carbaldehyde, 98%, 250mg

Acide 5,5'-dithio-bis-(-2-nitrobenzoïque), min 98 %, pa, 25 g, emballage en verre

Solution de formaldéhyde 30 %, faible teneur en méthanol, 1 l

TERT-BUTYL 3-(AMINOMETHYL)-3-METHYLAZEPANE-1-CARBOXYLATE, 95.0%, 250mg

[2,2'-Bipyridine]-4,4'-diyldiboronic acid, 97%, 250mg

2-Benzyl-2-dimethylamino-1-(4-morpholinophenyl)-1-butanone, 95.0%, 10g

Filtres respiratoires série DT (ex Pro2000), A2-P3, DT-4041E, 1 pièce